Moderna says updated next-generation COVID shot shows strong immune response in patients

Core Insights - Moderna's updated COVID-19 vaccine formulation has shown a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying health condition [1] Company Summary - The company has focused on enhancing its vaccine formulation to improve immune responses among older adults and those with underlying health issues [1]